Distribution of brain sodium accumulation correlates with disability in multiple sclerosis: A cross-sectional23Na MR imaging study

Radiology

Volumn 264, Issue 3, 2012, Pages 859-867

  Zaaraoui, Wafaa ^a   Konstandin, Simon ^b   Audoin, Bertrand ^a,c   Nagel, Armin M ^d   Rico, Audrey ^a,c   Malikova, Irina ^a,c   Soulier, Elisabeth ^a   Viout, Patrick ^a   Confort Gouny, Sylviane ^a   Cozzone, Patrick J ^a   Pelletier, Jean ^a,c   Schad, Lothar R ^b   Ranjeva, Jean Philippe ^a  

^a University of Aix Marseille   (France)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c TIMONE HOSPITAL   (France)

^d GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

SODIUM; SODIUM 23;

ADULT; ARTICLE; BRAIN LEVEL; BRAIN MAPPING; BRAIN STEM; CEREBELLUM; CLINICAL ARTICLE; CONTROLLED STUDY; DEMYELINATION; DISABILITY; DISEASE DURATION; EXPANDED DISABILITY STATUS SCALE; FEMALE; GRAY MATTER; HUMAN; MALE; MOTOR SYSTEM; MULTIPLE SCLEROSIS; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; TEMPORAL LOBE; THREE DIMENSIONAL IMAGING; WHITE MATTER;

ADULT; AREA UNDER CURVE; BRAIN; DISABILITY EVALUATION; FEMALE; HUMANS; IMAGE ENHANCEMENT; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; REGRESSION ANALYSIS; SODIUM; STATISTICS, NONPARAMETRIC;

EID: 84865409372     PISSN: 00338419     EISSN: 15271315     Source Type: Journal    
DOI: 10.1148/radiol.12112680     Document Type: Article

References (31)

1. Kutzelnigg A, Lucchinetti CF, Stadelmann C, et al. Cortical demyelination and diffuse white matter injury in multiple sclerosis. Brain 2005;128(Pt 11):2705-2712.
2. Lassmann H, Brück W, Lucchinetti CF. The immunopathology of multiple sclerosis: an overview. Brain Pathol 2007;17(2):210-218.
3. Bjartmar C, Wujek JR, Trapp BD. Axonal loss in the pathology of MS: consequences for understanding the progressive phase of the disease. J Neurol Sci 2003;206(2):165-171.
4. Lassmann H. Axonal and neuronal pathology in multiple sclerosis: what have we learnt from animal models. Exp Neurol 2010;225(1):2-8.
5. Mahad D, Lassmann H, Turnbull D. Review: mitochondria and disease progression in multiple sclerosis. Neuropathol Appl Neurobiol 2008;34(6):577-589.
6. Chard D, Miller D. Grey matter pathology in clinically early multiple sclerosis: evidence from magnetic resonance imaging. J Neurol Sci 2009;282(1-2):5-11.
7. Smith KJ. Sodium channels and multiple sclerosis: roles in symptom production, damage and therapy. Brain Pathol 2007;17(2):230-242.
8. Stys PK. General mechanisms of axonal damage and its prevention. J Neurol Sci 2005;233(1-2):3-13.
9. Waxman SG. Axonal conduction and injury in multiple sclerosis: the role of sodium channels. Nat Rev Neurosci 2006;7(12):932-941.
10. Waxman SG. Mechanisms of disease: sodium channels and neuroprotection in multiple sclerosis - current status. Nat Clin Pract Neurol 2008;4(3):159-169.
11. Craner MJ, Hains BC, Lo AC, Black JA, Waxman SG. Co-localization of sodium channel Nav1.6 and the sodium-calcium exchanger at sites of axonal injury in the spinal cord in EAE. Brain 2004;127(Pt 2):294-303.
12. Boada FE, LaVerde G, Jungreis C, Nemoto E, Tanase C, Hancu I. Loss of cell ion homeostasis and cell viability in the brain: what sodium MRI can tell us. Curr Top Dev Biol 2005;70:77-101.
13. Hilal SK, Maudsley AA, Ra JB, et al. In vivo NMR imaging of sodium-23 in the human head. J Comput Assist Tomogr 1985;9(1):1-7.
14. Ouwerkerk R. Sodium MRI. Methods Mol Biol 2011;711:175-201.
15. Inglese M, Madelin G, Oesingmann N, et al. Brain tissue sodium concentration in multiple sclerosis: a sodium imaging study at 3 tesla. Brain 2010;133(Pt 3):847-857.
16. Polman CH, Reingold SC, Banwell B, et al. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol 2011;69(2):292-302.
17. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983;33(11):1444-1452.
18. Nagel AM, Laun FB, Weber MA, Matthies C, Semmler W, Schad LR. Sodium MRI using a density-adapted 3D radial acquisition technique. Magn Reson Med 2009;62(6):1565-1573.
19. Coupe P, Yger P, Prima S, Hellier P, Kervrann C, Barillot C. An optimized block-wise nonlocal means denoising filter for 3-D magnetic resonance images. IEEE Trans Med Imaging 2008;27(4):425-441.
20. Ranjeva JP, Audoin B, Au Duong MV, et al. Local tissue damage assessed with statistical mapping analysis of brain magnetization transfer ratio: relationship with functional status of patients in the earliest stage of multiple sclerosis. AJNR Am J Neuroradiol 2005;26(1):119-127.
21. Brück W, Bitsch A, Kolenda H, Brück Y, Stiefel M, Lassmann H. Inflammatory central nervous system demyelination: correlation of magnetic resonance imaging findings with lesion pathology. Ann Neurol 1997;42(5):783-793.
22. Black JA, Newcombe J, Waxman SG. Astrocytes within multiple sclerosis lesions upregulate sodium channel Nav1.5. Brain 2010;133(Pt 3):835-846.
23. Sontheimer H, Waxman SG. Ion channels in spinal cord astrocytes in vitro. II. Biophysical and pharmacological analysis of two Na+ current types. J Neurophysiol 1992;68(4):1001-1011.
24. Sontheimer H, Fernandez-Marques E, Ullrich N, Pappas CA, Waxman SG. Astrocyte Na+ channels are required for maintenance of Na+/K(+)-ATPase activity. J Neurosci 1994;14(5 Pt 1):2464-2475.
25. Evangelou N, Konz D, Esiri MM, Smith S, Palace J, Matthews PM. Regional axonal loss in the corpus callosum correlates with cerebral white matter lesion volume and distribution in multiple sclerosis. Brain 2000;123(Pt 9):1845-1849.
26. Audoin B, Fernando KT, Swanton JK, Thompson AJ, Plant GT, Miller DH. Selective magnetization transfer ratio decrease in the visual cortex following optic neuritis. Brain 2006;129(Pt 4):1031-1039.
27. Paling D, Golay X, Wheeler-Kingshott C, Kapoor R, Miller D. Energy failure in multiple sclerosis and its investigation using MR techniques. J Neurol 2011;258(12):2113-2127.
28. Bar-Or A, Rieckmann P, Traboulsee A, Yong VW. Targeting progressive neuroaxonal injury: lessons from multiple sclerosis. CNS Drugs 2011;25(9):783-799.
29. Dutta R, McDonough J, Yin X, et al. Mitochondrial dysfunction as a cause of axonal degeneration in multiple sclerosis patients. Ann Neurol 2006;59(3):478-489.
30. Kutzelnigg A, Faber-Rod JC, Bauer J, et al. Widespread demyelination in the cerebellar cortex in multiple sclerosis. Brain Pathol 2007;17(1):38-44.
31. Geurts JJ, Bö L, Roosendaal SD, et al. Extensive hippocampal demyelination in multiple sclerosis. J Neuropathol Exp Neurol 2007;66(9):819-827.